Table 3.
rank | CUI | Gene Concept | R value | percentile | PubMed ID |
---|---|---|---|---|---|
2 ★ | C1537910 | MIRLET7A1 | 1.04687 | 0.006818% | |
2 ★ | C1537912 | MIRLET7A3 | 1.04687 | 0.006818% | |
3 ★ | C0079419 | TP53 | 1.04684 | 0.010227% | |
4 ★ | C0919524 | ATM | 1.03027 | 0.013637% | |
5 ✓ | C0376571 | BRCA1 | 1.00283 | 0.017046% | 8807330 |
6 ★ | C1333544 | FGFR4 | 0.966285 | 0.020455% | |
7 ✓ | C0242957 | ERBB2 | 0.961433 | 0.023864% | 9797688 |
8 ✓ | C0694884 | MEN1 | 0.939749 | 0.027273% | 15168774 |
9 ✓ | C0162832 | APC | 0.93778 | 0.030682% | 11448917 |
10 ✓ | C0694872 | CDH1 | 0.934644 | 0.034091% | 11597316 |
11 ★ | C1537713 | MIR17 | 0.933832 | 0.037500% | |
12 ✓ | C1332802 | CTLA4 | 0.914895 | 0.040910% | 16527605 |
13 ★ | C1336686 | TSSC4 | 0.91024 | 0.044319% | |
14 ✓ | C1537734 | MIR29B2 | 0.899002 | 0.047728% | 19639033 |
15 ★ | C1537859 | MIR221 | 0.898388 | 0.051137% | |
16 ✓ | C0812241 | BRAF | 0.896812 | 0.054546% | 12068308 |
17 ★ | C1825998 | MIR20A | 0.896133 | 0.057955% | |
18 ★ | C1337001 | WNT3 | 0.893316 | 0.061364% | |
19 ★ | C1537773 | MIR126 | 0.884353 | 0.064773% | |
20 ✓ | C0812265 | ERBB3 | 0.88357 | 0.068183% | 1333787 |
21 ✓ | C1332416 | BIRC5 | 0.882932 | 0.071592% | 16873289 |
22 ★ | C0694883 | STK11 | 0.882428 | 0.075001% | |
23 ✓ | C0812267 | ERBB4 | 0.874504 | 0.078410% | 15735025 |
24 ★ | C1836306 | MIR124-1 | 0.871343 | 0.081819% | |
25 ✓ | C1333206 | DDR1 | 0.871328 | 0.085228% | 10923103 |
26 ✓ | C1537715 | MIR19A | 0.869182 | 0.088637% | 21059650 |
27 | C1537699 | MIR1-1 | 0.868504 | 0.092047% | |
28 ★ | C1335274 | PTK6 | 0.867511 | 0.095456% | |
29 ✓ | C1835840 | MIR29B1 | 0.86677 | 0.098865% | 21359530 |
30 ✓ | C0694889 | RB1 | 0.860263 | 0.102274% | 11108660 |
Confirmed disease gene concepts (by available links connecting genes to Breast Carcinoma) are marked by ★. Gene concepts having been studied for Breast Carcinoma in literature are marked by ✓. One paper for each of these gene concepts is listed by its PubMed ID.